Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KOTITI is a South Korea-based testing, inspection, and certification organization that provides analytical, quality, and regulatory support services across textiles, consumer products, environmental testing, mobility, and bio-health. In healthcare-related activities, it offers testing and inspection services for pharmaceuticals, quasi-drugs, food, and cosmetics, including physicochemical testing, microbial limit testing, stability studies, antiviral activity testing, and impurity analysis. The institute is designated by Korean authorities for multiple regulated testing functions, including pharmaceutical and quasi-drug testing under MFDS oversight. KOTITI appears to operate primarily as a commercial service provider rather than a therapeutic drug developer, so it does not have a traditional clinical pipeline. Its role in life sciences is best characterized as a contract testing and compliance partner supporting product quality, safety, and market access.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KOTITI.